

Currently released so far... 12478 / 251,287
Browse latest releases
2010/12/01
2010/12/02
2010/12/03
2010/12/04
2010/12/05
2010/12/06
2010/12/07
2010/12/08
2010/12/09
2010/12/10
2010/12/11
2010/12/12
2010/12/13
2010/12/14
2010/12/15
2010/12/16
2010/12/17
2010/12/18
2010/12/19
2010/12/20
2010/12/21
2010/12/22
2010/12/23
2010/12/24
2010/12/25
2010/12/26
2010/12/27
2010/12/28
2010/12/29
2010/12/30
2011/01/01
2011/01/02
2011/01/04
2011/01/05
2011/01/07
2011/01/09
2011/01/10
2011/01/11
2011/01/12
2011/01/13
2011/01/14
2011/01/15
2011/01/16
2011/01/17
2011/01/18
2011/01/19
2011/01/20
2011/01/21
2011/01/22
2011/01/23
2011/01/24
2011/01/25
2011/01/26
2011/01/27
2011/01/28
2011/01/29
2011/01/30
2011/01/31
2011/02/01
2011/02/02
2011/02/03
2011/02/04
2011/02/05
2011/02/06
2011/02/07
2011/02/08
2011/02/09
2011/02/10
2011/02/11
2011/02/12
2011/02/13
2011/02/14
2011/02/15
2011/02/16
2011/02/17
2011/02/18
2011/02/19
2011/02/20
2011/02/21
2011/02/22
2011/02/23
2011/02/24
2011/02/25
2011/02/26
2011/02/27
2011/02/28
2011/03/01
2011/03/02
2011/03/03
2011/03/04
2011/03/05
2011/03/06
2011/03/07
2011/03/08
2011/03/09
2011/03/10
2011/03/11
2011/03/13
2011/03/14
2011/03/15
2011/03/16
2011/03/17
2011/03/18
2011/03/19
2011/03/20
2011/03/21
2011/03/22
2011/03/23
2011/03/24
2011/03/25
2011/03/26
2011/03/27
2011/03/28
2011/03/29
2011/03/30
2011/03/31
2011/04/01
2011/04/02
2011/04/03
2011/04/04
2011/04/05
2011/04/06
2011/04/07
2011/04/08
2011/04/09
2011/04/10
2011/04/11
2011/04/12
2011/04/13
2011/04/14
2011/04/15
2011/04/16
2011/04/17
2011/04/18
2011/04/19
2011/04/20
2011/04/21
2011/04/22
2011/04/23
2011/04/24
2011/04/25
2011/04/26
2011/04/27
2011/04/28
2011/04/29
2011/04/30
Browse by creation date
Browse by origin
Embassy Athens
Embassy Asuncion
Embassy Astana
Embassy Asmara
Embassy Ashgabat
Embassy Apia
Embassy Ankara
Embassy Amman
Embassy Algiers
Embassy Addis Ababa
Embassy Accra
Embassy Abuja
Embassy Abu Dhabi
Embassy Abidjan
Consulate Auckland
Consulate Amsterdam
Consulate Adana
American Institute Taiwan, Taipei
Embassy Bujumbura
Embassy Buenos Aires
Embassy Budapest
Embassy Bucharest
Embassy Brussels
Embassy Bridgetown
Embassy Bratislava
Embassy Brasilia
Embassy Bogota
Embassy Bishkek
Embassy Bern
Embassy Berlin
Embassy Belmopan
Embassy Belgrade
Embassy Beirut
Embassy Beijing
Embassy Banjul
Embassy Bangkok
Embassy Bandar Seri Begawan
Embassy Bamako
Embassy Baku
Embassy Baghdad
Consulate Barcelona
Embassy Copenhagen
Embassy Conakry
Embassy Colombo
Embassy Chisinau
Embassy Caracas
Embassy Canberra
Embassy Cairo
Consulate Curacao
Consulate Ciudad Juarez
Consulate Chennai
Consulate Casablanca
Consulate Cape Town
Consulate Calgary
Embassy Dushanbe
Embassy Dublin
Embassy Doha
Embassy Djibouti
Embassy Dili
Embassy Dhaka
Embassy Dar Es Salaam
Embassy Damascus
Embassy Dakar
Consulate Dubai
Embassy Helsinki
Embassy Harare
Embassy Hanoi
Consulate Ho Chi Minh City
Consulate Hermosillo
Consulate Hamilton
Consulate Hamburg
Consulate Halifax
Embassy Kyiv
Embassy Kuwait
Embassy Kuala Lumpur
Embassy Kinshasa
Embassy Kingston
Embassy Kigali
Embassy Khartoum
Embassy Kathmandu
Embassy Kampala
Embassy Kabul
Consulate Kolkata
Embassy Luxembourg
Embassy Luanda
Embassy London
Embassy Ljubljana
Embassy Lisbon
Embassy Lima
Embassy Lilongwe
Embassy La Paz
Consulate Lahore
Consulate Lagos
Mission USOSCE
Mission USNATO
Mission UNESCO
Embassy Muscat
Embassy Moscow
Embassy Montevideo
Embassy Monrovia
Embassy Minsk
Embassy Mexico
Embassy Mbabane
Embassy Maputo
Embassy Manila
Embassy Manama
Embassy Managua
Embassy Malabo
Embassy Madrid
Consulate Munich
Consulate Mumbai
Consulate Montreal
Consulate Monterrey
Consulate Milan
Consulate Melbourne
Embassy Nicosia
Embassy Niamey
Embassy New Delhi
Embassy Ndjamena
Embassy Nassau
Embassy Nairobi
Consulate Naples
Consulate Naha
Embassy Pristina
Embassy Pretoria
Embassy Prague
Embassy Port Of Spain
Embassy Port Louis
Embassy Port Au Prince
Embassy Phnom Penh
Embassy Paris
Embassy Paramaribo
Embassy Panama
Consulate Peshawar
REO Basrah
Embassy Rome
Embassy Riyadh
Embassy Riga
Embassy Reykjavik
Embassy Rangoon
Embassy Rabat
Consulate Rio De Janeiro
Consulate Recife
Secretary of State
Embassy Suva
Embassy Stockholm
Embassy Sofia
Embassy Skopje
Embassy Singapore
Embassy Seoul
Embassy Sarajevo
Embassy Santo Domingo
Embassy Santiago
Embassy Sanaa
Embassy San Salvador
Embassy San Jose
Consulate Strasbourg
Consulate St Petersburg
Consulate Shenyang
Consulate Shanghai
Consulate Sapporo
Consulate Sao Paulo
Embassy Tunis
Embassy Tripoli
Embassy Tokyo
Embassy The Hague
Embassy Tel Aviv
Embassy Tehran
Embassy Tegucigalpa
Embassy Tbilisi
Embassy Tashkent
Embassy Tallinn
Consulate Toronto
Consulate Tijuana
USUN New York
USEU Brussels
US Office Almaty
US Mission Geneva
US Interests Section Havana
US Delegation, Secretary
UNVIE
Embassy Ulaanbaatar
Embassy Vilnius
Embassy Vienna
Embassy Vatican
Embassy Valletta
Consulate Vladivostok
Consulate Vancouver
Browse by tag
AU
ASEC
AE
AF
AORC
AEMR
AMGT
ABUD
AFFAIRS
APER
AS
AMED
AY
AG
AR
AJ
AL
AID
AM
AODE
ABLD
AMG
AFIN
ATRN
AGAO
AFU
AN
AA
ALOW
APECO
ADM
ARF
ASEAN
APEC
AMBASSADOR
AO
ASUP
AZ
AADP
ACOA
ANET
AMCHAMS
ACABQ
ASECKFRDCVISKIRFPHUMSMIGEG
APCS
AGMT
AINF
AIT
AORL
ACS
AFSI
AFSN
ACBAQ
AFGHANISTAN
ADANA
ADPM
AX
ADCO
AECL
AMEX
ACAO
ASCH
AORG
AGR
AROC
ASIG
AND
ARM
AQ
ATFN
AC
AUC
ASEX
AER
AVERY
AGRICULTURE
BL
BR
BO
BA
BD
BM
BK
BG
BU
BB
BH
BTIO
BY
BEXP
BP
BE
BRUSSELS
BF
BIDEN
BT
BX
BC
BILAT
BN
BBSR
BTIU
BWC
BMGT
CA
CASC
CVIS
CM
CH
CO
CU
CD
CWC
CI
CS
CY
CMGT
CF
CG
CR
CB
CV
CW
CE
CBW
CT
CPAS
COUNTERTERRORISM
CJAN
CODEL
CIDA
CDG
CDC
CIA
CTR
CNARC
CSW
CN
CONS
CLINTON
COE
CROS
CARICOM
CONDOLEEZZA
COUNTER
CL
COM
CICTE
CIS
CFED
COUNTRY
CJUS
CBSA
CEUDA
CLMT
CAC
COPUOS
CIC
CBE
CHR
CTM
CVR
CITEL
CLEARANCE
CACS
CAN
CITT
CARSON
CACM
CDB
CAPC
CKGR
CBC
EC
EG
EPET
ECON
ETRD
EFIN
EIND
EMIN
ENRG
EAID
EAGR
EUN
ETTC
EAIR
ENIV
ES
EU
EINV
ELAB
ECIN
EFIS
ELTN
EWWT
ECPS
ECONOMIC
ENGR
EN
EINT
EPA
ELN
ESA
EZ
ER
ET
EFTA
EINVECONSENVCSJA
EUMEM
ETRA
EXTERNAL
EI
EUR
EK
ERNG
ENGY
ETRDEINVECINPGOVCS
ENERG
EINVEFIN
ENVR
ECA
ELECTIONS
ETC
EUREM
ENNP
EFINECONCS
EURN
ECINECONCS
EEPET
EXIM
ERD
ENVI
ETRC
ETRDEINVTINTCS
ETRO
EDU
ETRN
EAIG
ECONCS
ECONOMICS
EAP
ECONOMY
EINN
EIAR
EXBS
ECUN
EINDETRD
EREL
EUC
ESENV
ECONEFIN
ECIP
EFIM
EAIDS
ETRDECONWTOCS
EUNCH
EINVETC
IZ
IT
IR
IS
IN
IC
IAEA
IO
ICAO
IWC
ID
IV
ISRAEL
IAHRC
IQ
ICTR
IMF
IRS
IDP
IGAD
ICRC
ICTY
IMO
IL
INRA
INRO
ICJ
ITU
IBRD
INMARSAT
IIP
ITALY
IEFIN
IACI
ILO
INTELSAT
ILC
ITRA
IDA
INRB
IRC
INTERPOL
IA
IPR
IRAQI
ISRAELI
INTERNAL
ISLAMISTS
INDO
ITPHUM
ITPGOV
ITALIAN
IBET
INR
IEA
IZPREL
IRAJ
ITF
IF
KDEM
KU
KPAL
KNNP
KCRM
KZ
KN
KS
KJUS
KTFN
KSCA
KV
KISL
KPAO
KPKO
KIRF
KTIA
KIPR
KFLO
KFRD
KTIP
KAWC
KSUM
KCOM
KAID
KE
KTDB
KMDR
KOMC
KWBG
KDRG
KVPR
KTEX
KGIC
KWMN
KSCI
KCOR
KACT
KDDG
KHLS
KSAF
KFLU
KSEO
KMRS
KSPR
KOLY
KSEP
KVIR
KGHG
KIRC
KUNR
KIFR
KCIP
KMCA
KMPI
KBCT
KHSA
KICC
KIDE
KCRS
KMFO
KRVC
KRGY
KR
KAWK
KG
KFIN
KHIV
KBIO
KOCI
KBTR
KNEI
KPOA
KCFE
KPLS
KSTC
KHDP
KPRP
KCRCM
KLIG
KCFC
KTER
KREC
KTBT
KPRV
KSTH
KRIM
KRAD
KWAC
KWMM
KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG
KOMS
KX
KMIG
KRCM
KVRP
KBTS
KPAONZ
KNUC
KNAR
KPWR
KNPP
KDEMAF
KNUP
KNNPMNUC
KERG
KGIT
KPAI
KTLA
KFSC
KCSY
KSAC
KTRD
KID
KOM
KMOC
KJUST
KGCC
KREL
KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG
KFTFN
KO
KNSD
KHUM
KSEC
KCMR
KCHG
KICA
KPIN
KESS
KDEV
KCGC
KWWMN
KPAK
KWNM
KWMNCS
KRFD
MOPS
MCAP
MPOS
MARR
MO
MNUC
MX
MASS
MG
MY
MU
ML
MR
MILITARY
MTCRE
MT
MEPP
MA
MDC
MP
MAR
MASSMNUC
MARAD
MAPP
MZ
MD
MI
MEETINGS
MK
MCC
MEPN
MRCRE
MAS
MIL
MASC
MC
MV
MTCR
MIK
MUCN
MEDIA
MERCOSUR
MW
MOPPS
MTS
MLS
MILI
MTRE
MEPI
MQADHAFI
MAPS
NO
NATO
NL
NP
NZ
NSF
NI
NH
NG
NAFTA
NU
NASA
NR
NATOPREL
NSSP
NSG
NA
NT
NW
NK
NPT
NPA
NATIONAL
NPG
NSFO
NS
NSC
NE
NGO
NDP
NIPP
NRR
NEW
NZUS
NC
NAR
NV
NORAD
OTRA
OPCW
OVIP
OAS
OREP
OPIC
OIIP
OPRC
ODIP
OEXC
OPDC
OSCE
OIC
OSCI
OECD
OFDP
OFDA
OMIG
OPAD
OFFICIALS
OVP
OIE
OHUM
OCS
OBSP
OTR
OSAC
ON
OCII
OES
PGOV
PREL
PHUM
PTER
PINS
PINR
PREF
PK
PROP
PA
PARM
PBTS
PMAR
PM
PGIV
PE
PRAM
PHUH
PHSA
PL
PNAT
PO
PLN
PAO
PSA
PHUMPGOV
PF
PEL
PBIO
POLITICS
PHUMBA
PAS
POL
PREO
PAHO
PMIL
POGOV
POV
PAK
PNR
PRL
PG
PREFA
PSI
PINL
PU
PARMS
PRGOV
PALESTINIAN
PAIGH
POLITICAL
PARTIES
POSTS
PROG
PORG
PTBS
PUNE
POLICY
PDOV
PCI
PGOVSMIGKCRMKWMNPHUMCVISKFRDCA
PBT
PP
PS
PY
PTERE
PGOF
PKFK
PSOE
PEPR
PPA
PINT
PRELP
PSEPC
PGOVE
PINF
PNG
PGOC
PFOR
PCUL
POLINT
PGGV
PHALANAGE
PARTY
PGOVLO
PHUS
PDEM
PECON
PROV
PHUMPREL
RS
RU
RELATIONS
RW
RO
RM
RP
ROOD
RICE
RUPREL
RSO
RCMP
REACTION
REPORT
REGION
RIGHTS
RF
RFE
RSP
RIGHTSPOLMIL
ROBERT
SU
SCUL
SNAR
SOCI
SF
SA
SHUM
SENV
SP
SR
SY
SANC
SC
SMIG
SZ
SARS
SW
SEVN
SO
SEN
SL
SNARCS
SNARN
SI
SG
SN
SH
SYR
SAARC
SPCE
SHI
SCRS
SENVKGHG
SYRIA
SWE
STEINBERG
SIPRS
ST
SNARIZ
SSA
SK
SPCVIS
SOFA
SIPDIS
SAN
TC
TI
TBIO
TH
TSPL
TRGY
TSPA
TPHY
TU
TW
TS
TAGS
TK
TX
TNGD
TZ
TF
TL
TV
TN
TD
TIP
TR
TP
TO
TT
TFIN
THPY
TERRORISM
TINT
TRSY
TURKEY
TBID
US
UK
UNGA
UP
UZ
UNMIK
USTR
UNO
UNSC
UN
UNESCO
UNAUS
UNHRC
UY
UG
UNHCR
UNCND
USOAS
USEU
UNICEF
UNEP
UV
UNPUOS
UNCSD
USUN
UNCHR
UNDC
USNC
UE
UNDP
UNC
USPS
USAID
UNVIE
UAE
UNFICYP
UNODC
UNCHS
UNIDROIT
UNDESCO
UNCHC
Browse by classification
Community resources
courage is contagious
Viewing cable 04QUEBEC12, FDA INTERNET PHARMACY MEETINGS IN QUEBEC CITY
If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:
- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #04QUEBEC12.
Reference ID | Created | Released | Classification | Origin |
---|---|---|---|---|
04QUEBEC12 | 2004-01-20 18:07 | 2011-04-28 00:00 | UNCLASSIFIED//FOR OFFICIAL USE ONLY | Consulate Quebec |
This record is a partial extract of the original cable. The full text of the original cable is not available.
201807Z Jan 04
UNCLAS SECTION 01 OF 03 QUEBEC 000012
SIPDIS
SENSITIVE
OTTAWA FOR ECON GALLEGHER
STATE FOR WHA/CAN EWHEELER, EB/IPC SWILSON, EB/TPP/BTA/EWH DSHEEHAN
STATE PASS HSS PLAISIER AND MCGINNIS
E.O. 12958: N/A
TAGS: ECON ETRD CA FDA
SUBJECT: FDA INTERNET PHARMACY MEETINGS IN QUEBEC CITY
¶1. Summary: FDA representatives met with Quebec officials
January 12 to discuss the internet pharmacy trade and other
issues related to an upcoming meeting between FDA Commissioner
McClellan and Premier Charest in Davos. In his meeting with
Commissioner McClellan, Premier Charest is likely to ask when
the U.S. will implement the rest of legislation on U.S.
pharmaceutical imports. Despite differences in federal and
provincial systems, the Health Canada representative present
offered Ottawa's full support to Quebec on cross-border
enforcement investigations relating to provincial regulations.
Health Canada is moving forward with unannounced compliance
inspections on internet sites starting in February to examine
how regulations were being applied to these sites. End Summary
¶2. FDA Assistant Commissioner for International Programs
Melinda Plaisier and Director of Pharmacy Affairs Thomas
McGinnis had two meetings on January 19 to discuss the internet
pharmacy trade in Quebec. The first was with provincial
officials; the second with provincial pharmacy regulators, and a
Health Canada representative. The genesis of the meetings was a
request by Premier Charest to meet with Commissioner McClellan
in Davos January 23 to discuss the pharmacy issue, and concerns
about the impact of new U.S. bioterrorism regulations relating
to cross-border trade. FDA indicated that Commissioner
McClellan might also raise potential GMO labeling legislation in
Quebec.
--------------------------------------------- --------------
----------
QUEBEC REGULATING INTERNET PHARMACIES
--------------------------------------------- --------------
----------
¶3. The President of the Quebec Order of Pharmacists (OQP)
Jean-Yves Julien and the Director of Investigations Jocelyn
Binet, representing the regulatory side of Quebec's
pharmaceutical industry, stressed the strict enforcement and
control regime on internet pharmacies in Quebec. Only about 4
% of the orders placed with Canadian internet pharmacies are
received in Quebec. Quebec is the only jurisdiction in North
America where one must be a registered pharmacist to own a
pharmacy, thereby affording strong legal remedies for violators.
He reported that no pharmacists in Quebec own internet sites
inside the province. In any case, OQP would oppose internet
pharmacies because they would not meet their professional
standards. Currently three internet sites in the Montreal area
are being sued, by the OQP, for selling medication abroad.
¶4. Prescriptions signed by U.S. physicians are not valid in
Quebec. Internet pharmacy businesses look for Canadian-licensed
doctors to co-sign or rewrite them without a consultation -- an
unethical practice, said Julien. Based on the Quebec code of
ethics, physicians and pharmacists must have face-to-face
contact with the patient or can be sued by the disciplinary
committee. Julien said, moreover, that his pharmacists are no
longer accepting a co-signature by a Canadian doctor at face
value.
¶5. As the head of Quebec's pharmaceutical licensing body, Julien
underscored that pharmacists were not mere vendors or
distributors of drugs, but provided a professional service, a
dimension that he felt was too often neglected in the internet
pharmacy debate. The OQP is taking a very comprehensive look at
the safety and quality of the cross-border drug trade, with a
particular emphasis on services such as the appropriateness of
medications. Quebec passed new legislation last year, Bill 90,
that allows pharmacists to adjust prescriptions made by
physicians and request follow up procedures such as blood tests.
Pharmacists maintain the security of drugs and services and can
be sued for practices against the public interest. At this
time, at least one person is being sued personally for "illegal
exercise of a profession." The case is pending a decision by a
Superior Court judge. Julien also noted, in passing, that
direct advertising by drug firms to consumers is prohibited in
Quebec, making it easier for physicians to prescribe less
expensive drugs.
¶6. Chief investigator Binet told the FDA officials that the
OQP, the federal RCMP, and DEA officials based in the state of
Vermont have been working closely together on a number of cases.
He said that cross-border enforcement is extremely difficult
because of the complexity of getting Canadian law enforcement
officials across the U.S./Canada border. Cross-border travel in
the OQP investigations were facilitated only by virtue of
personal contacts within U.S. law enforcement, which insured
that a briefed-inspector was on the border when needed. The FDA
visitors offered to assist in facilitating entry into the U.S.
of an investigator, should the case arise again.
--------------------------------------------- ------------
LONGER TERM REPERCUSSIONS
---------------------------- -----------------------------
¶7. Representatives of two Quebec ministries, Laval Poulin,
Director of Intergovernmental Affairs at the Ministry of
Agriculture, and Richard St Cyr of the Ministry of Economic
Development, expressed concern about the potential impact on the
local health care situation because heightened demand for
prescription drugs from the U.S. In his meeting with
Commissioner McClellan, Premier Charest is likely to ask when
the U.S. will implement the rest of legislation on U.S.
pharmaceutical imports. Quebec is concerned that one impact
could be pressure to increase prices of drugs for the province's
universal medical plan.
¶8. FDA's Plaisier pointed to the exponential growth of the
international cyber drug trade over the last decade. While it
is an issue in several countries, recently the spotlight has
fallen on Canada. Pressure in the U.S. to provide access to
less expensive prescription drugs may give rise to new
legislation in Congress. FDA has been mandated to report back
to Congress by December on how to bridge the gap between the
U.S. and Canadian systems, said McGinnis. There are real
concerns about transshipments, drug subpotency and quality.
Counterfeiting is a huge concern. Drugs subject to a recall can
be swapped out and redistributed with a date change. Since last
summer, a number of controlled substances have begun to flow
into the country, i.e. codeine, valium, and ephedrine (diet
pills). Some of this is originating for the first time from
Canada. The Quebec side said they saw no trend toward
controlled drug exports from the province: pharmacists report
cross border visitors were buying largely medications for blood
pressure control, cholesterol, and erectile problems).
-------------------------
HEALTH CANADA
-------------------------
¶9. The meetings elicited lively and useful exchanges between
the FDA, Quebec provincial officials, OQP, and Health Canada.
Health Canada Associate Director General Daniele Dionne offered
full federal support to Quebec. She said Ottawa was ready to
work more closely with provincial regulatory bodies. FDA
officials were struck her notification that Health Canada was
moving forward with unannounced compliance inspections on
internet sites starting in February to examine how regulations
were being applied on these sites. Dionne said her Ministry and
FDA had recently signed an MOU on information sharing and
pledged to remain in close contact in this regard. She also
stressed the need for close federal/provincial cooperation.
With safety as the principal concern, she underscored that none
of the 6000 pharmacists in Quebec are involved in illegal
internet practices; cyber companies are going elsewhere because
of Quebec's effective regulatory system.
------------------------------
BIO- TERRORISM ACT
-----------------------------
¶10. As the U.S. is Quebec's number one client in terms of food
exports, BTA legislation has a direct impact; the Charest
government has provided comments through the federal government.
Quebec's main concern is prior notification for importation
into the States: the province's concerns were reflected in the
initial regulations. Poulin said the province appreciated the
8-month soft enforcement period. The industry and farmers need
time to adjust; they are hopeful they will be adequately
prepared when the Act comes into full effect next summer. So
far, there has been no appreciable impact on the border, but the
program is new and it is still winter. The 8-month soft
enforcement period would end in the middle of the fresh produce
period. For the time being, transportation companies only
receive warnings at the border. Quebec representatives asked
whether it would be possible to harmonize the BTA regulations
with existing the FAST and CPAT programs at the border. FDA
replied that the initial BTA regulations were drawn up under a
tight deadline, but that there would be another 30-day comment
period in March.
----------------------
GMO LABELING
----------------------
¶11. Asked about potential food labeling legislation, the Quebec
officials said a parliamentary commission had been formed to
look at food safety. Under this umbrella the commission may
examine and suggest legislation on GMO labeling. The committee
is expected to report to the National Assembly in the spring.
Public hearings will follow. Both the federal and provincial
governments share jurisdiction on food labeling and must
harmonize their approach. Inter-provincial and international
trade is under federal jurisdiction while internal provincial
trade is under Quebec control.
¶12. Comment: The FDA representatives underlined that America
was primarily focused on safety issues, and the point was made
more effectively than has often been the case because they
emphasized that high American demand for drugs, combined with
the curtailing of deliveries by drug producers, would create
market pressures that would inevitably open the path to
counterfeiters and undermine even the efforts of even the best
regulatory authorities. This message was well received by the
Quebec side, for whom legal and professional (safety) issues are
as much at stake as political and economic concerns. The
participants all focused on the longer-term potential for
problems caused by the cross-border internet pharmacy trade.
Health Canada's participation was appreciated in that it allowed
the Quebec side to differentiate between provincial and federal
systems in a way that elicited cooperation.
KEOGH